Novo Nordisk Annual Report 2012
Detailed App Info:
Application Description
Novo Nordisk’s Annual Report 2012 accounts for the company’s financial, social and environmental performance in one integrated report. The app provides an enhanced user experience through easy navigation and comprehensive linking between the articles and the statements.
This is Novo Nordisk’s first Annual Report app and we welcome your feedback. Does the app meet your information needs? Is it comprehensible? Is it user-friendly? You can help improve our reporting by answering a few questions at novonordisk.com/annualreport/feedback.
About Novo Nordisk
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 34,700 employees in 75 countries, and markets its products in more than 180 countries.
This is Novo Nordisk’s first Annual Report app and we welcome your feedback. Does the app meet your information needs? Is it comprehensible? Is it user-friendly? You can help improve our reporting by answering a few questions at novonordisk.com/annualreport/feedback.
About Novo Nordisk
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 34,700 employees in 75 countries, and markets its products in more than 180 countries.
Requirements
Your mobile device must have at least 30.75 MB of space to download and install Novo Nordisk Annual Report 2012 app. Novo Nordisk Annual Report 2012 was updated to a new version. Purchase this version for $0.00
If you have any problems with installation or in-app purchase, found bugs, questions, comments about this application, you can visit the official website of Novo Nordisk A/S at http://www.novonordisk.com/investors/default.asp.
Copyright © Novo Nordisk A/S
